Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;55(1):50-58.
doi: 10.1161/STROKEAHA.123.044281. Epub 2023 Dec 22.

Omega-3 Blood Levels and Stroke Risk: A Pooled and Harmonized Analysis of 183 291 Participants From 29 Prospective Studies

James H O'Keefe  1 Nathan L Tintle  2 William S Harris  2   3 Evan L O'Keefe  1 Aleix Sala-Vila  2   4 John Attia  5 G Manohar Garg  5 Alexis Hure  5 Christian Sørensen Bork  6 Erik Berg Schmidt  7 Stine Krogh Venø  8 Kuo-Liong Chien  9 Yun-Yu Amelia Chen  10 Sarah Egert  11 Tobias Rudholm Feldreich  12 Johan Ärnlöv  13 Lars Lind  14 Nita G Forouhi  15 Johanna M Geleijnse  16 Kamalita Pertiwi  16 Fumiaki Imamura  15 Vanessa de Mello Laaksonen  17 W Matti Uusitupa  17 Jaakko Tuomilehto  17 Markku Laakso  18 Maria Anneli Lankinen  17 Danielle Laurin  19 Pierre-Hugues Carmichael  19 Joan Lindsay  20 Karin Leander  21 Federica Laguzzi  21 Brenton R Swenson  22 William T Longstreth  23 JoAnn E Manson  24 Samia Mora  24 Nancy R Cook  24 Matti Marklund  25   26   27 Debora Melo van Lent  28 Rachel Murphy  29 Vilmundur Gudnason  30 Toshihara Ninomiya  31 Yoichiro Hirakawa  31 Frank Qian  32 Qi Sun  33 Frank Hu  33 Andres V Ardisson Korat  34 Ulf Risérus  35 Iolanda Lázaro  4 Cecilia Samieri  36 Mélanie Le Goff  36 Catherine Helmer  36 Marinka Steur  37 Trudy Voortman  37 M Kamran Ikram  37 Toshiko Tanaka  38 Jayanta K Das  39 Luigi Ferrucci  38 Stefania Bandinelli  40 Michael Tsai  41 Weihua Guan  42 Parveen Garg  43 W M Monique Verschuren  44   45 Jolanda M A Boer  46 Anneke Biokstra  46 Jyrki Virtanen  17 Michael Wagner  47 Jason Westra  2 Luc Albuisson  48 Kazumasa Yamagishi  49 David S Siscovick  50 Rozenn N Lemaitre  51 Dariush Mozaffarian  52
Affiliations

Omega-3 Blood Levels and Stroke Risk: A Pooled and Harmonized Analysis of 183 291 Participants From 29 Prospective Studies

James H O'Keefe et al. Stroke. 2024 Jan.

Erratum in

Abstract

Background: The effect of marine omega-3 PUFAs on risk of stroke remains unclear.

Methods: We investigated the associations between circulating and tissue omega-3 PUFA levels and incident stroke (total, ischemic, and hemorrhagic) in 29 international prospective cohorts. Each site conducted a de novo individual-level analysis using a prespecified analytical protocol with defined exposures, covariates, analytical methods, and outcomes; the harmonized data from the studies were then centrally pooled. Multivariable-adjusted HRs and 95% CIs across omega-3 PUFA quintiles were computed for each stroke outcome.

Results: Among 183 291 study participants, there were 10 561 total strokes, 8220 ischemic strokes, and 1142 hemorrhagic strokes recorded over a median of 14.3 years follow-up. For eicosapentaenoic acid, comparing quintile 5 (Q5, highest) with quintile 1 (Q1, lowest), total stroke incidence was 17% lower (HR, 0.83 [CI, 0.76-0.91]; P<0.0001), and ischemic stroke was 18% lower (HR, 0.82 [CI, 0.74-0.91]; P<0.0001). For docosahexaenoic acid, comparing Q5 with Q1, there was a 12% lower incidence of total stroke (HR, 0.88 [CI, 0.81-0.96]; P=0.0001) and a 14% lower incidence of ischemic stroke (HR, 0.86 [CI, 0.78-0.95]; P=0.0001). Neither eicosapentaenoic acid nor docosahexaenoic acid was associated with a risk for hemorrhagic stroke. These associations were not modified by either baseline history of AF or prevalent CVD.

Conclusions: Higher omega-3 PUFA levels are associated with lower risks of total and ischemic stroke but have no association with hemorrhagic stroke.

Keywords: atrial fibrillation; cerebrovascular disease; fish; fish oil; stroke.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr O’Keefe reports major ownership interest in Cardiotabs. Dr Harris reports minor ownership interest in Omegaquant Analytics, LLC. Dr Sala-Vila reports travel and grant support from California Walnut Commission. Dr Mora reports compensation for consultant services from Quest Diagnostics. Dr Murphy reports compensation from Pharmavite for consultant services. Dr Bork reports grants from Karen Elise Jensens Fond. Dr Ärnlöv reports compensation from Astellas Pharma for other services; compensation from Boehringer Ingelheim for consultant services; compensation from AstraZeneca for other services; and compensation from Novartis for other services. Dr Geleijnse reports grants from National Institutes of Health to other; grants from Upfield Europe BV to other; and grants from The Dutch Heart Foundation to other. Dr Manson reports grants from National Institutes of Health and compensation from National Institutes of Health for other services. Dr Mora reports compensation from Pfizer for consultant services; employment by Brigham and Women’s Hospital; grants from National Institute of Diabetes and Digestive and Kidney Diseases; and grants from National Heart, Lung, and Blood Institute. Dr Melo van Lent reports grants from National Institutes of Health and grants from Alzheimer’s Association. Dr Mozaffarian reports grants from Rockefeller Foundation; compensation from Beren Therapeutics for other services; stock holdings in HumanCo; compensation from January Inc. for other services; compensation from Filtricine for other services; compensation from Perfect Day for other services; compensation from Tiny Organics for other services; grants from Bill and Melinda Gates Foundation; compensation from Calibrate for other services; grants from Vail Innovative Global Research; grants from Kaiser Permanente Fund at East Bay Community Foundation; compensation from DayTwo for other services; compensation from Instacart health for other services; compensation from Season Health for other services; grants from National Institutes of Health; compensation from Barilla for consultant services; stock holdings in Calibrate; compensation from Kaiser Permanente Fund for other services; compensation from HumanCo for other services

Figures

Figure 1 –
Figure 1 –
Association of DHA and risk of stroke
Figure 2 –
Figure 2 –
Association of DHA and risk of stroke by lipid compartment

References

    1. Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018;38:208–211. - PubMed
    1. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;2:117–119. - PubMed
    1. DiNicolantonio JJ, O’Keefe JH. The Benefits of Omega-3 Fats for Stabilizing and Remodeling Atherosclerosis. Mo Med. 2020;117:65–69. - PMC - PubMed
    1. O’Keefe EL, Harris WS, DiNicolantonio JJ, Elagizi A, Milani RV, Lavie CJ, O’Keefe JH. Sea Change for Marine Omega-3s: Randomized Trials Show Fish Oil Reduces Cardiovascular Events. Mayo Clin Proc. 2019;94:2524–2533. - PubMed
    1. Cheng P, Huang W, Bai S, Wu Y, Yu J, Zhu X, Qi Z, Shao W, Xie P. BMI Affects the Relationship between Long Chain N-3 Polyunsaturated Fatty Acid Intake and Stroke Risk: a Meta-Analysis. Sci Rep. 2015;5:14161. - PMC - PubMed